Rx-Spending Growth Slows But Remains One Of The Fastest Growing Sectors

Drug spending growth slowed from 9 percent in 2015 to 6 percent last year due to a drop in use of hepatitis C drugs, according to 2016 projections that the CMS actuary's office reported Wednesday (Feb. 15). The actuaries' projections of health-spending growth overall are slightly slower than they were last year, even though spending in Medicare and Medicaid is expected to speed up a bit, and the ACA's Independent Payment Advisory Board is still projected to be triggered this...